83
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Association between calcifying nanoparticles and placental calcification

, , , &
Pages 1679-1686 | Published online: 27 Mar 2012

Figures & data

Figure 1 Transmission electron micrograph of calcifying nanoparticles. (A) Calcifying nanoparticles between 50 nm to 500 nm in diameter showing different electron-dense shells in calcified placental tissues. (B) Nucleic acid-like materials distributed within the individual calcifying nanoparticles in the extracellular matrix. (C) A calcifying nanoparticle self-divided into two. (D) Calcifying nanoparticles with thin shells exiting placental villus. (E) Single calcifying nanoparticles among hydroxyapatite crystals in calcified placental tissues.

Note: Bar indicates magnification of 200 nm.

Figure 1 Transmission electron micrograph of calcifying nanoparticles. (A) Calcifying nanoparticles between 50 nm to 500 nm in diameter showing different electron-dense shells in calcified placental tissues. (B) Nucleic acid-like materials distributed within the individual calcifying nanoparticles in the extracellular matrix. (C) A calcifying nanoparticle self-divided into two. (D) Calcifying nanoparticles with thin shells exiting placental villus. (E) Single calcifying nanoparticles among hydroxyapatite crystals in calcified placental tissues.Note: Bar indicates magnification of 200 nm.
Figure 1 Transmission electron micrograph of calcifying nanoparticles. (A) Calcifying nanoparticles between 50 nm to 500 nm in diameter showing different electron-dense shells in calcified placental tissues. (B) Nucleic acid-like materials distributed within the individual calcifying nanoparticles in the extracellular matrix. (C) A calcifying nanoparticle self-divided into two. (D) Calcifying nanoparticles with thin shells exiting placental villus. (E) Single calcifying nanoparticles among hydroxyapatite crystals in calcified placental tissues.Note: Bar indicates magnification of 200 nm.

Figure 2 Growth curve of calcifying nanoparticles cultured in vitro under cell culture conditions.

Note: Mean OD650 values were recorded up to 4 weeks.

Abbreviation: OD, optical density.

Figure 2 Growth curve of calcifying nanoparticles cultured in vitro under cell culture conditions.Note: Mean OD650 values were recorded up to 4 weeks.Abbreviation: OD, optical density.

Figure 3 Transmission electron micrograph of calcifying nanoparticles cultured in vitro for four weeks. (A) Calcifying nanoparticles appear as oval-shaped particles with highly electron-dense shells. (B) Calcifying nanoparticles without shells.

Note: Bar indicates magnification of 200 nm.

Figure 3 Transmission electron micrograph of calcifying nanoparticles cultured in vitro for four weeks. (A) Calcifying nanoparticles appear as oval-shaped particles with highly electron-dense shells. (B) Calcifying nanoparticles without shells.Note: Bar indicates magnification of 200 nm.

Figure 4 Analysis of target 16S rRNA gene sequences from different cultured calcifying nanoparticle samples. Lane M, DNA marker (Trans2K plus DNA marker); lane 1–6, genes from different calcifying nanoparticle samples cultured under the same conditions.

Figure 4 Analysis of target 16S rRNA gene sequences from different cultured calcifying nanoparticle samples. Lane M, DNA marker (Trans2K plus DNA marker); lane 1–6, genes from different calcifying nanoparticle samples cultured under the same conditions.

Figure 5 Analysis of target 16S rRNA gene sequences from different samples of calcified placental tissues and normal placental tissues. Lane M, DNA marker (Trans2K plus DNA marker); lane 1, negative polymerase chain reaction control without primers; lane 2, negative polymerase chain reaction control without templates; lane 3–4, genes from normal placental tissues samples; lane 5–6, genes from different calcium samples.

Figure 5 Analysis of target 16S rRNA gene sequences from different samples of calcified placental tissues and normal placental tissues. Lane M, DNA marker (Trans2K plus DNA marker); lane 1, negative polymerase chain reaction control without primers; lane 2, negative polymerase chain reaction control without templates; lane 3–4, genes from normal placental tissues samples; lane 5–6, genes from different calcium samples.